Contact Points
Rockville, MD 20850
from CSF listed herein is available from only one source, and competition is precluded for the
reasons indicated below. There are no substitutes available.
There is currently no treatment for ALS -4 due to mutations in SETX. A prerequisite for developing treatments is to identify protein biomarkers that may be monitored in biofluids like CSF that track with disease progression and treatment response. A method for identifying proteomic biomarkers is called proteomics. Olink Explore HT has developed a platform which can measure more than one thousand validated protein biomarkers from less than 100 uL of CSF sample. CSF from patient samples is a very precious resource , therefore it is critical that the platforms used be robust and provide the most data from a small amount of sample. It is also critical that the data be comparable to collaborators within the NIH and to leading biomarker studies worldwide, such as the UK Biobank study, both of which have used the Olink platform.
Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.